Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer

Conditions: Prostate Adenocarcinoma; Stage IIB Prostate Cancer AJCC v8; Stage IIC Prostate Cancer AJCC v8
Interventions: Procedure: Biospecimen Collection; Other: Contrast Agent; Drug: Leuprolide; Procedure: Magnetic Resonance Imaging; Other: Physical Performance Testing; Drug: Relugolix
Sponsors: Ohio State University Comprehensive Cancer Center; Pfizer; Myovant Sciences GmbH; Sumitomo Pharmaceuticals America
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 28, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments